Natera announces follow-on offering of $100 million in company shares

Natera Inc., cell-free DNA testing company, announced the launch of a follow-on public offering of $100,000,000 in shares of its common stock, according to a press release from the company.

Additionally, Natera expects to grant a 30-day option to purchase up to an additional $15,000,000 of shares of its common stock to its underwriters. According to the release, these will be sold at the public offering price less the underwriting discount.

Natera said that J.P. Morgan, Cowen and Piper Jaffray are acting as joint book-running managers for the offering. Also, Baird and Canaccord Genuity will be acting co-managers for the offering.

The offering is subject to market and other conditions. Therefore, the company said there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Reference:

www.natera.com/press-releases/natera-launches-proposed-follow-offering-0